An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown

Neuropharmacology

Volumn 55, Issue 7, 2008, Pages 1156-1164

  Galeotti, N ^a   Vivoli, E ^a   Norcini, M ^a   Bartolini, A ^a   Ghelardini, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antidepressant; Heparin; Inositol 1,4,5 trisphosphate receptor; Intracellular calcium; Knockdown mice

Indexed keywords

AMITRIPTYLINE; ANTISENSE OLIGONUCLEOTIDE; CLOMIPRAMINE; DEXAMPHETAMINE; HEPARIN; INOSITOL; INOSITOL 1,4,5 TRIPHOSPHATE RECEPTOR 1; INOSITOL 1,4,5 TRIPHOSPHATE RECEPTOR 2; INOSITOL 1,4,5 TRIPHOSPHATE RECEPTOR 3; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; LITHIUM CHLORIDE; UNCLASSIFIED DRUG; XESTOSPONGIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; FORCED SWIMMING TEST; GENE SEQUENCE; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; LOCOMOTION; MALE; MOOD DISORDER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN CHEMISTRY; DEPRESSION; GENE KNOCKDOWN TECHNIQUES; IMMUNOPRECIPITATION; INJECTIONS, INTRAVENTRICULAR; INOSITOL; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LITHIUM CHLORIDE; MACROCYCLIC COMPOUNDS; MALE; MICE; MOTOR ACTIVITY; OLIGONUCLEOTIDES, ANTISENSE; OXAZOLES; POSTURAL BALANCE; RNA, MESSENGER; SWIMMING;

EID: 54049126058     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.07.029     Document Type: Article

References (56)

1. Berridge M.J. Inositol trisphosphate and calcium signaling. Nature 361 (1993) 315-325
2. Berridge M.J. Neuronal calcium signaling. Neuron 21 (1998) 13-26
3. Bohus M., Forstmner U., Kiefer C., Gebicke-Harter P., Timmer J., Spraul G., Wark H.J., Hecht H., Berger M., and van Calker D. Increased sensitivity of the inositol-phospholipid system in neutrophils from patients with acute major depressive episode. Psychiatry Research 65 (1996) 45-51
4. Ciccolini F., Collins T.J., Sudhoelter J., Lipp P., Berridge M.J., and Bootman M.D. Local and global spontaneous calcium events regulate neurite outgrowth and onset of GABAergic phenotype during neural precursor differentiation. Journal of Neuroscience 23 (2003) 103-111
5. Dubovsky S.L., Thomas M., Hijazi A., and Murphy J. Intracellular calcium signaling in peripheral cells of patients with bipolar disorder. European Archives of Psychiatry Clinical Neuroscience 243 (1994) 229-234
6. 3H]inositol 1,4,5-trisphosphate binding sites and expressed inositol 1,4,5-trisphosphate receptor protein level in platelets of depressed patients. Psychopharmacology 138 (1998) 47-54
7. Eckert A., Riemann G.D., Aldenhoff J., and Mueller W.E. Elevated intracellular calcium levels after 5HT2 receptor stimulation in platelets of depressed patients. Biological Psychiatry 34 (1993) 565-568
8. Emamghoreishi M., Schlichter L., Li P.P., Parikh S., Sen J., Kamble A., and Warsh J.J. High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorders. American Journal of Psychiatry 154 (1997) 976-982
9. Finch E.A., Turner T.J., and Goldin S.M. Calcium as a coagonist of inositol 1,4,5-trisphosphate-induced calcium release. Science 252 (1991) 443-446
10. 2+ release channels. Physiological Reviews 87 (2007) 593-658
11. Futatsugi A., Nakamura T., Yamada M.K., Ebisui E., Nakamura K., Uchida K., Kitaguchi T., Takahashi-Iwanaga H., Noda T., Aruga J., and Mikoshiba K. IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 309 (2005) 2232-2234
12. Gafni J., Munsch J.A., Lam T.H., Catlin M.C., Costa L.G., Molinski T.F., and Pessah I.N. Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron 19 (1997) 723-733
13. Galeotti N., Bartolini A., and Ghelardini C. The phospholipase C-IP3 pathway is involved in muscarinic antinociception. Neuropsychopharmacology 28 (2003) 888-897
14. Galeotti N., Quattrone A., Vivoli E., Bartolini A., and Ghelardini C. Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. Neuroscience 149 (2007) 409-420
15. Haug L.S., Ostvold A.C., Cowburn R.F., Garlind A., Winblad B., Bogdanovich N., and Walaas S.I. Decreased 1 inositol 1,4,5-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severity. Neurodegeneration 5 (1996) 169-176
16. 2+ dependence of inositol 1,4,5-trisphosphate-induced Ca release in smooth muscle cells of the guinea pig taenia caeci. Journal of General Physiology 95 (1990) 1103-1122
17. Jonas S., Sugimori M., and Llinas R. Low molecular weight heparin a neuroprotectant?. Annals of New York Academy of Sciences 825 (1997) 389-393
18. Karege F., Bovier P., Rudolph W., and Gaillard J.M. Platelet phosphoinositide signaling system: an overstimulated pathway in depression. Biological Psychiatry 39 (1996) 697-702
19. 2+-binding proteins. EMBO Journal 23 (2004) 312-321
20. Kim H., Rhyu I.J., Kim C.M., Suh Y.S., Park J.B., Kang U.G., and Kim Y.S. Electroconvulsive shock reduces inositol trisphosphate receptor 1 mRNA in rat brain. Molecular Cells 12 (2001) 173-177
21. ++ response is increased in the blood platelets of depressed patients. Biological Psychiatry 30 (1991) 310-312
22. Kusumi I., Koyama T., and Yamashita I. Thrombin-induced platelet calcium mobilization is enhanced in bipolar disorders. Biological Psychiatry 32 (1992) 731-734
23. Maluquer S.S., Arranz B., and San L. Depression improvement with calcium heparin. General Hospital Psychiatry 24 (2002) 448-454
24. Matsumoto M., and Nagata E. Type 1 inositol 1,4,5-trisphosphate receptor knock-out mice: their phenotypes and their meaning in neuroscience and clinical practice. Journal of Molecular Medicine 77 (1999) 406-411
25. Matsumoto M., Nakagawa T., Inoue T., Nagata E., Tanaka K., Takano H., Minowa O., Kuno J., Sakakibara S., Yamada M., Yoneshima H., Miyawaki A., Fukuuchi Y., Furuichi T., Okano H., Mikoshiba K., and Noda T. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 379 (1996) 168-171
26. Mattson M.P., and Chan S.L. Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 34 (2003) 385-397
27. Mikoshiba K. The InsP3 receptor and intracellular Ca2+ signaling. Current Opinion in Neurobiology 7 (1997) 339-345
28. Mikuni M., Kagaya A., Takahashi K., and Meltzer H.Y. Serotonin, but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology 106 (1992) 311-314
29. Mikuni M., Kusimi I., Kagaya A., Kuroda Y., Mori H., and Takahashi K. Increased 5-HT2 receptor function as measured by serotonin stimulated phosphoinsitide hydrolysis in platelets of depressed patients. Biological Psychiatry 15 (1991) 49-61
30. 2+ homeostasis and disease. Cell Calcium 28 (2000) 1-21
31. 2+ wave trigger zone of the pancreatic acinar cells. Journal of Biological Chemistry 269 (1994) 4693-4696
32. Ogura H., Matsumoto M., and Mikoshiba K. Motor discoordination in mutant mice heterozygous for the type 1 inositol 1,4,5-trisphosphate receptor. Behavioural Brain Research 122 (2001) 215-219
33. Pacheco M.A., Stockmeier C., Meltzer H.Y., Overholser J.C., Dilley G.E., and Jope R.S. Alterations in phosphoinositide signaling and G protein levels in depressed suicide brains. Brain Research 723 (1996) 37-45
34. Pandey G.N., Ren X., Pandey S.C., Dwivedi Y., Sharma R., and Janicak P.G. Hyperactive phosphoinositide signaling pathway in platelets of depressed patients: effect of desipramine treatment. Psychiatry Research 105 (2001) 23-32
35. Patel S., Joseph S.K., and Thomas A.P. Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium 25 (1999) 247-264
36. Petit-Demouliere B., Chenu F., and Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 111 (2005) 245-255
37. Phiel C.J., and Klein P.S. Molecular targets of lithium action. Annual Reviews of Pharmacology and Toxicology 41 (2001) 789-813
38. Porsolt R.D., Bertin A., and Jalfre M. Behavioural despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 229 (1977) 327-336
39. Rosel P., Arranz B., San L., Vallejo J., Crespo J.M., Urretavizcaya M., and Navarro M.A. Altered 5-HT2A binding sites and second messenger inositol trisphosphate (IP3) levels in hippocampus but not in frontal cortex from depressed suicide victims. Psychiatry Research 99 (2000) 173-181
40. Ross C.A., Danoff S.K., Schell M.J., Snyder S.H., and Ullrich A. Three additional inositol 1,4,5-triphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. Proceedings of National Academy of Sciences 89 (1992) 4265-4269
41. Schlecker C., Boehmerle W., Jeromin A., DeGray B., Vrashney A., Sharma Y., Szigeti-Buck K., and Whrlich B. Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. Journal of Clinical Investigation 116 (2006) 1668-1674
42. Sharp A.H., Nucifora F.C., Blondel O., Sheppard C.A., Zhang C.Y., Snyder S.H., Russel J.T., Ryugo D.K., and Ross C.A. Differential cellular expression of isoforms of inositol 1,4,5-triphosphate receptors in neurons and glia in brain. Journal of Comparative Neurology 406 (1999) 207-220
43. 2+ waves in cultured astrocytes. Journal of Neurochemistry 68 (1997) 2317-2327
44. Shibao K., Hirata K., Robert M., and Nathanson M. Loss of 1 inositol 1,4,5-trisphosphate receptor from bile duct epithelia is a common event in cholestasis. Gastroenterology 125 (2003) 1175-1187
45. Shimon H., Agam G., Belmaker R.H., Hyde T.M., and Kleinman J.E. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorders. American Journal of Psychiatry 254 (1997) 1148-1150
46. Simpson P.B., Mehotra S., Lange G.D., and Russel J.T. High density distribution of endoplasmic reticulum proteins and mitochondria at specialized Ca2+ release sites in oligodendrocyte processes. Journal of Biological Chemistry 272 (1997) 22654-22661
47. Soares J.C., Dippold C.S., Wells K.F., Fran K.E., Kupfer D.J., and Mallinger A.G. Increased platelet membrane phospoinositidyl-inositol-4,5-bisphosphate in drug-free depressed bipolar patients. Neuroscience Letters 299 (2001) 150-152
48. Street V.A., Bosma M.M., Demas V.P., Regan M.R., Lin D.D., and Robinson L.C. The type 1 inositol 1,4,5-trisphosphate receptor gene is altered in the episthotonos mouse. Journal of Neuroscience 17 (1997) 635-645
49. Suzuki K., Kusumi I., Sasaki Y., and Koyama T. Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders: is it specific to bipolar disorders?. Affective Disorders 64 (2001) 291-296
50. Tang T.S., Tu H., Chan E.Y., Maximov A., Wang Z., Wellington C.L., Hayden M.R., and Bezprozvanny I. Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by 1 inositol 1,4,5-trisphosphate receptor type 1. Neuron 39 (2003) 227-239
51. Taylor C.W., Genazzani A.A., and Morris S.A. Expression of inositol trisphosphate receptors. Cell Calcium 26 (1999) 237-251
52. Tomiyoshi R., Kamei K., Muraoka S., Muneoka K., and Takigawa M. Serotonin-induced platelet intracellular calcium responses in untreated depressed patients and imipramine responders in remission. Biological Psychiatry 45 (1999) 1042-1048
53. Vaught J., Pelley K., Costa L.G., Sether P., and Enna S.J. A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen. Neuropharmacology 24 (1985) 211-216
54. Zalk R., Lehnart S.E., and Mark A.R. Modulation of the ryanodine receptor and intracellular calcium. Annual Reviews of Biochemistry 76 (2007) 367-385
55. Zecevic N., Milosevic A., and Ehrlich B.E. Calcium signaling molecules in human cerebellum at midgestation and in ataxia. Early Human Development 54 (1999) 103-116
56. Zhang S.X., Zhang J.P., Fletcher D.L., Zoeller R.T., and Sun G.Y. In situ hybridization of mRNA expression for IP3 receptor and IP3-3-kinase in rat brain after transient focal cerebral ischemia. Brain Research Molecular Brain Research 32 (1995) 252-260